Emerging as potential therapeutic targets for AD, purinergic receptors, especially the P2 × 7R subtype found on microglia, play dual roles in neuroprotection and neurodegeneration (Burnstock, 2016; Woods et al., 2016). This evidence concerns the gene P2RY2 and Alzheimer disease.